Healthcare Services

Ventral Hernia Treatment Market Forecast with Demand and Industry Growth Insights

April 28, 2026April 30, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Much Growth In Market Value Is Expected For The Ventral Hernia Treatment Market Between 2026 And 2030?

The ventral hernia treatment market has experienced robust expansion in recent years. Projections indicate that it will rise from $5.22 billion in 2025 to $5.59 billion in 2026, with a compound annual growth rate (CAGR) of 7.2%. Historically, this expansion has stemmed from factors such as an uptick in abdominal hernia cases, higher rates of surgical interventions, wider acceptance of laparoscopic surgery, increased access to surgical mesh products, and better use of diagnostic imaging.

The market for ventral hernia treatments is projected to experience substantial expansion over the upcoming years. This market is anticipated to reach $7.3 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 6.9%. This projected growth during the forecast period is driven by factors such as the increasing integration of robotic surgery platforms, a surging demand for tension-free repair methods, the proliferation of ambulatory surgical centers, an amplified emphasis on mitigating hernia recurrence rates, and increased financial commitments to cutting-edge surgical technologies. Key trends emerging within the forecast timeframe encompass the wider embrace of robotic-assisted hernia repair, a notable increase in the utilization of advanced hernia mesh materials, a heightened inclination towards minimally invasive surgical approaches, the broadening availability of day-care surgical treatments, and enhanced post-surgical recovery guidelines.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21315&type=smp

What Factors Are Contributing To The Growth Of The Ventral Hernia Treatment Market?

The rising incidence of obesity is projected to boost the expansion of the ventral hernia treatment market in the future. Obesity, a medical condition, involves an excessive accumulation of body fat that profoundly affects an individual’s well-being. The growing occurrence of obesity stems from factors such as unhealthy eating habits, inactive lifestyles, genetic predispositions, insufficient physical exercise, environmental elements, and psychological pressure. Ventral hernia treatment offers assistance to obesity patients by managing the difficulties stemming from excessive weight, by helping to lessen tension on the abdominal wall, decreasing the likelihood of hernia recurrence, and improving overall abdominal strength, which is crucial for fostering mobility and encouraging more healthful lifestyle decisions among those living with obesity. For example, in March 2024, the World Health Organization (WHO), a Switzerland-based intergovernmental organization, indicated that around one in eight individuals globally faced obesity. This figure comprised 2.5 billion adults (aged 18 years and older) who were overweight, with 890 million of these experiencing obesity. Among the adult population, 43% were overweight, and 16% were categorized as obese. Furthermore, the population of overweight children under the age of 5 reached 37 million. Consequently, the expanding prevalence of obesity is a key driver for the ventral hernia treatment market.

How Is The Ventral Hernia Treatment Market Segmented Across Different Segment Categories?

The ventral hernia treatment market covered in this report is segmented –

1) By Type: Epigastric (Stomach Area) Hernia, Umbilical (Belly Button) Hernia, Incisional Hernia

2) By Diagnosis: Ultrasound, Computed Tomography (CT) Scan, Magnetic Resonance Imaging (MRI)

3) By Surgery: Open Hernia Surgery, Laparoscopic Surgery, Robotic Hernia Surgery

4) By End Users: Hospitals, Ambulatory Surgical Centres, Clinics

Subsegments:

1) By Epigastric (Stomach Area) Hernia: Small Epigastric Hernia, Large Epigastric Hernia

2) By Umbilical (Belly Button) Hernia: Congenital Umbilical Hernia, Acquired Umbilical Hernia

3) By Incisional Hernia: Primary Incisional Hernia, Recurrent Incisional Hernia

What Trends Are Shaping The Future Of The Ventral Hernia Treatment Market?

Major companies engaged in the ventral hernia treatment market are emphasizing technological advancements, including laparoscopic and open hernia mesh fixation devices, to enhance surgical outcomes, lessen complications, and improve patient recovery. Laparoscopic and open hernia mesh fixation devices are medical instruments utilized to secure mesh during hernia repair surgeries, through either minimally invasive (laparoscopic) or traditional open surgical approaches. For example, in March 2024, TELA Bio Inc., a US-based medical technology company, launched its LIQUIFIX FIX8 laparoscopic and LIQUIFIX precision open hernia mesh fixation devices in the U.S. LIQUIFIX FIX8 is designated for minimally invasive repairs, while LIQUIFIX precision is intended for open femoral and inguinal hernia repairs. These FDA-approved devices function by using liquid anchors to fasten mesh without penetrating tissue, thereby decreasing trauma and complications. With over 1.2 million hernia procedures conducted annually in the U.S., LIQUIFIX provides accuracy and safety in sensitive areas and minimizes the risks of vascular or nerve injury.

Which Organizations Play A Role In The Ventral Hernia Treatment Market Landscape?

Major companies operating in the ventral hernia treatment market are Johnson & Johnson Services Inc., Medtronic Plc, Becton, Dickinson and Company (BD), Braun Melsungen AG, Olympus Corporation, W.L. Gore and Associates Inc, STERIS Plc, Cook Medical Inc, KARL STORZ, Cooper University Health Care, Mölnlycke Health Care, Integra LifeSciences Holdings, ConMed Corporation, Aesculap Inc, Richard Wolf GmbH, Ethicon Inc, Microline Surgical, Hernia Mesh S.R.L., Insightra Medical Inc, Advanced MedTech Solutions Pvt Ltd

Get The Full Ventral Hernia Treatment Market Report:

https://www.thebusinessresearchcompany.com/report/ventral-hernia-treatment-global-market-report

Which Region Is The Leading Market For The Ventral Hernia Treatment Market?

North America was the largest region in the ventral hernia treatment market in 2025. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the ventral hernia treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Ventral Hernia Treatment Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/ventral-hernia-treatment-global-market-report

Browse Through More Reports Similar to the Global Ventral Hernia Treatment Market 2026, By The Business Research Company

Hernia Mesh Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/hernia-mesh-devices-global-market-report

Congenital Diaphragmatic Hernia Drugs Market Report

https://www.thebusinessresearchcompany.com/report/congenital-diaphragmatic-hernia-drugs-global-market-report

Sarcopenia Treatment Market Report

https://www.thebusinessresearchcompany.com/report/sarcopenia-treatment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795